Citizens Financial Group’s Integra LifeSciences IART Stock Holding History

Citizens Financial Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-100	Closed	-$7K	–	552
2018 Q3	$7K	Buy	+100	New	+$6.21K	﹤0.01%	445
2017 Q2	–	Sell	-171	Closed	-$7K	–	567
2017 Q1	$7K	Sell	171 -47	-22%	-$2.01K	﹤0.01%	467
2016 Q4	$9K	Hold	218	–	–	﹤0.01%	455
2016 Q3	$9K	Sell	218 -12	-5%	-$503	﹤0.01%	460
2016 Q2	$9K	Buy	230 +146	+174%	+$5.25K	﹤0.01%	479
2016 Q1	$3K	Hold	84	–	–	﹤0.01%	553
2015 Q4	$3K	Buy	+84	New	+$2.63K	﹤0.01%	611

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citizens Financial Group's IART Position: Q4 2018 in Review

Citizens Financial Group sold out of Integra LifeSciences (IART) in Q4 2018, closing a stake of 100 shares — an estimated $7K sold.

Citizens Financial Group first reported a position in IART in Q4 2015 and held it in 7 quarters. The position peaked at $9K in Q4 2016. 248 funds tracked by Wall St. Rank hold IART as of Q4 2018.

Citizens Financial Group reported no remaining Integra LifeSciences position as of Q4 2018 after selling out during the quarter.
Citizens Financial Group sold 100 Integra LifeSciences shares in Q4 2018, an estimated $7K.
Citizens Financial Group first reported a position in Integra LifeSciences in Q4 2015 and held it in 7 quarters.
Citizens Financial Group's Integra LifeSciences position peaked at $9K in Q4 2016.
248 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2018.

Based on Citizens Financial Group's 13F filing for Q4 2018, filed 11 Feb 2019.